P670: ABSENCE OF BTK, BCL2, AND PLCG2 MUTATIONS IN RELAPSING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AFTER FIRST‐LINE TREATMENT WITH FIXED‐DURATION IBRUTINIB (I) PLUS VENETOCLAX (V)
- Resource Type
- Article
- Source
- HemaSphere; 2022 Supplement 3, Vol. 6, p568-569, 2p
- Subject
- Language
- ISSN
- 25729241